Adam Hesse, CEO at Full Spectrum, details the difficulties MedTech companies face when investing in AI and high-tech applications, often struggling to yield significant return on investment. Hesse details four common pitfalls: focusing too much on new technology, guessing and launching without a solid proof of concept, lack of data management, and absence of a clear financial model. He suggests a focused strategy, adequate data support infrastructure, and a clear connection between the AI initiative and the profit & loss account.
GenAI use in healthcare sparks rise in sensitive data violations
Healthcare workers are often uploading sensitive health data to personal cloud and AI accounts, says a report from Netskope Threat Labs. Out of the data
